Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Hydrocortisone in Patients With COVID-19 and Severe Hypoxia - the COVID STEROID Trial

NCT04348305 is registered in ClinicalTrials.gov with Scandinavian Critical Care Trials Group as lead sponsor.

NCT NCT04348305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Hydrocortisone in Patients With COVID-19 and Severe Hypoxia - the COVID STEROID Trial
Lead sponsor
Scandinavian Critical Care Trials Group
Phase
Phase 3
Overall status
Completed
Start date
April 17, 2020
Completion date
September 8, 2021
Enrollment
30 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, hypoxia